News & Features

Seven Bridges, a biomedical software and data analytics company, plans to expand operations into Novi Sad, Serbia, to meet growing demand for its products and services.

Combining wearable devices, handheld devices and digital apps lets researchers tell the difference between people with early dementia and those without it.

Researchers at Harvard Medical School have sequenced the genomes of a family in which multiple members had pancreatic cancer and found a mutation in a gene linked to the RAS signaling pathway that controls cell growth and death. Researchers argue that the into how RABL3 impacts the signaling pathway could lead to novel targeted therapy.

Researchers in Ireland are one step closer to offering seamless personalized care to epilepsy patients nationwide, reporting that they have developed a genomics module...

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...

The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...

More than 67 actionable clinical discoveries were made through deep longitudinal genomic analysis by a group led by Michael Snyder, MD, chair of the...

GNA Biosolutions GmbH's new funding will spur the German company’s molecular diagnostics assay development.

The companies will co-commercialize their respective single-cell technologies for CTCs and PD-L1 expression following positive study results

In the first Phase III trial ever to test maintenance treatment with a PARP inhibitor in pancreatic cancer, patients with germline BRCA1 or BRCA2...